Literature DB >> 10447330

Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8.

A Engel1, G Steinbach, P Kern, W V Kern.   

Abstract

We assessed the predictive value of procalcitonin (PCT) serum levels in neutropenic patients with fever and various types of infection, using a prospective 3 times weekly blood sampling protocol during 103 patient episodes. Compared with pre-fever levels, median PCT levels increased after fever onset from 0.16 ng/ml (day -1) to 0.34 ng/ml (day +1). In samples obtained within 32 h after fever onset, PCT levels differed significantly between (clinically or microbiologically) documented infection and unexplained fever (median 0.51 vs. 0.26 ng/ml), between bacteraemia and non-bacteraemic infection (median 0.8 vs. 0.27 ng/ml) and between Gram-negative bacteraemia and all other episodes (median 1.28 vs. 0.31 ng/ml). Receiver-operating-characteristic (ROC) curves indicated that the discriminatory power of PCT was best for predicting bacteraemia vs. non-bacteraemic infection (sensitivity 73%; specificity 86%; area under the ROC curve 0.795; cut-off value 0.5 ng/ml). Compared with interleukin-8 (IL-8) serum levels, test characteristics were similar in the prediction of bacteraemia vs. non-bacteraemic infection and in the prediction of documented infection vs. unexplained fever, while IL-8 was better than PCT in the prediction of Gram-negative bacteraemia (area under the ROC curve 0.965 vs. 0.758).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447330     DOI: 10.1080/003655499750006254

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  22 in total

1.  Pre-emptive antibiotic treatment vs 'standard' treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study.

Authors:  Ansgar Michael Chromik; Frank Endter; Waldemar Uhl; Arnulf Thiede; Hans Bernd Reith; Ulrich Mittelkötter
Journal:  Langenbecks Arch Surg       Date:  2005-12-21       Impact factor: 3.445

2.  A new prognostic model for chemotherapy-induced febrile neutropenia.

Authors:  Shin Ahn; Yoon-Seon Lee; Jae-Lyun Lee; Kyung Soo Lim; Sung-Cheol Yoon
Journal:  Int J Clin Oncol       Date:  2015-06-07       Impact factor: 3.402

3.  Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.

Authors:  Luis García de Guadiana-Romualdo; Ignacio Español-Morales; Pablo Cerezuela-Fuentes; Luciano Consuegra-Sánchez; Ana Hernando-Holgado; Patricia Esteban-Torrella; Enrique Jiménez-Santos; Monserrat Viqueira-González; África de Béjar-Almira; María Dolores Albaladejo-Otón
Journal:  Support Care Cancer       Date:  2015-01-07       Impact factor: 3.603

4.  Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies.

Authors:  M von Lilienfeld-Toal; A Schneider; K Orlopp; C Hahn-Ast; A Glasmacher; F Stüber
Journal:  Support Care Cancer       Date:  2006-05-30       Impact factor: 3.603

5.  Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation.

Authors:  M Sato; H Nakasone; K Terasako-Saito; K Sakamoto; R Yamazaki; Y Tanaka; Y Akahoshi; H Nakano; T Ugai; H Wada; R Yamasaki; Y Ishihara; K Kawamura; M Ashizawa; S-i Kimura; M Kikuchi; A Tanihara; J Kanda; S Kako; J Nishida; Y Kanda
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

Review 6.  Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis.

Authors:  Chun-Wei Wu; Jiunn-Yih Wu; Chun-Kuei Chen; Shiau-Ling Huang; Shou-Chien Hsu; Meng-Tse Gabriel Lee; Shy-Shin Chang; Chien-Chang Lee
Journal:  Support Care Cancer       Date:  2015-02-21       Impact factor: 3.603

7.  Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients.

Authors:  Nuray Buyukberber; Süleyman Buyukberber; Alper Sevinc; Celalettin Camci
Journal:  Med Oncol       Date:  2008-08-07       Impact factor: 3.064

8.  Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.

Authors:  M von Lilienfeld-Toal; M P Dietrich; A Glasmacher; L Lehmann; P Breig; C Hahn; I G H Schmidt-Wolf; G Marklein; S Schroeder; F Stuber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-22       Impact factor: 3.267

9.  Causes of fever and value of C-reactive protein and procalcitonin in differentiating infections from paraneoplastic fever.

Authors:  Nicolas Penel; Charles Fournier; Stéphanie Clisant; Michèle N'Guyen
Journal:  Support Care Cancer       Date:  2004-02-10       Impact factor: 3.603

10.  Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia.

Authors:  Shin Ahn; Yoon-Seon Lee; Kyung Soo Lim; Jae-Lyun Lee
Journal:  Support Care Cancer       Date:  2013-03-22       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.